AMPLEXA GENETICS A/S: Financial statements 2016
CVR: 29428441
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
AMPLEXA GENETICS A/S (CVR 29428441) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 439,860 and a net result of DKK -2,695,686 compared with DKK -3,373,569 the year before. That is an increase of 179.3% compared with the year before. Equity in the 2016 report amounted to DKK -22,278,092.
- Gross Profit
- DKK 439,860
- Profit/Loss
- DKK -2,695,686
- Equity
- DKK -22,278,092
- Total Assets
- DKK 2,704,566
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 440 t. | -2.7 mio. | -22.3 mio. | - |
| 2015 | - | 157 t. | -3.4 mio. | -19.6 mio. | - |
| 2014 | - | -186 t. | -3.4 mio. | -16.2 mio. | - |
| 2013 | - | -786 t. | -5.9 mio. | -12.8 mio. | - |
| 2012 | - | -538 t. | -2.1 mio. | -7 mio. | - |
Find more companies like AMPLEXA GENETICS A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
AMPLEXA GENETICS A/S has published its annual report for 2015. Gross profit came to DKK 157,496, and the net result was DKK -3,373,569.
About AMPLEXA GENETICS A/S
AMPLEXA GENETICS A/S is a Danish company of the type Aktieselskab based in Odense C, founded in 2006. The company is registered under the industry Anden teknisk rådgivning. The management consists of Hans Atli Eli Albinus Dahl. The company is owned by SCIENT. INVEST ApS, Conseco P/F and Sp/f D65 Holding. The company has 9 employees (2018). In 2025, the company reported a gross profit of DKK 4,009,035 and a net result of DKK -1,583,233 compared with DKK -11,108,344 the year before. Equity in the 2025 report amounted to DKK -10,313,267.